{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:32:43Z","timestamp":1774611163776,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771768"],"award-info":[{"award-number":["81771768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> There is no simple method for early diagnosis and evaluation of rheumatoid arthritis (RA). This study aimed to determine potential biomarkers and establish diagnostic patterns for RA using proteomic fingerprint technology combined with magnetic beads.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The serum protein profiles of 97 RA patients and 76 healthy controls (HCs) were analyzed by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) with weak cationic exchange (WCX) magnetic beads. Samples were randomly divided into training (83 RA patients and 56 HCs) and test sets (14 RA patients and 20 HCs). Patients were classified according to their Disease Activity Score: in remission, <jats:italic>n<\/jats:italic> = 28; with low disease activity, <jats:italic>n<\/jats:italic> = 17; with moderate disease activity, <jats:italic>n<\/jats:italic> = 21; with high disease activity, <jats:italic>n<\/jats:italic> = 31. There are 44 RA patients alone, 22 RA patients with interstitial lung disease (RA-ILD), 18 RA patients with secondary Sj\u00f6gren's syndrome (RA-sSS), 6 RA patients with osteonecrosis of the femoral head (RA-ONFH), and 7 RA patients with other complications. Eleven patients were treated with etanercept only for half a year, after which their serum protein profiles were detected. The proteomic pattern was identified by Biomarker Patterns Software, and the potential biomarkers for RA diagnosis were further identified and quantified by enzyme-linked immunosorbent assay.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The diagnostic pattern with four potential protein biomarkers, mass-to-charge (m\/z) 3,448.85, 4,716.71, 8,214.29, and 10,645.10, could accurately recognize RA patients from HCs (specificity, 91.57%; sensitivity, 92.86%). The test set were correctly classified by this model (sensitivity, 95%; specificity, 100%). The components containing the four biomarkers were preliminarily retrieved through the ExPasy database, including the C-C motif chemokine 24 (CCL24), putative metallothionein (MT1DP), sarcolipin (SLN), and C-X-C motif chemokine 11 (CCXL11). Only the CCL24 level was detected to have a significant decrease in the serum of RA patients as compared with HCs (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). No significant difference was found in others, but a decreasing trend consistent with the down-regulation of the four biomarkers detected by MALDI-TOF-MS was observed. The diagnostic models could effectively discriminate between RA alone and RA with complications (RA-ILD: m\/z 10,645.10 and 12,595.86; RA-sSS: m\/z 6,635.62 and 33,897.72; RA-ONFH: m\/z 2,071.689). The classification model, including m\/z 1,130.776, 1,501.065, 2,091.198, and 11,381.87, could distinguish between RA patients with disease activity and those in remission. RA with low disease activity could be efficiently discriminated from other disease activity patients by specific protein biomarkers (m\/z 2,032.31, 2,506.214, and Z9286.495). Two biomarkers (m\/z 2,032.31 and 4,716.71) were applied to build the classification model for RA patients with moderate and high disease activities. Biological markers for etanercept (m\/z 2,671.604064, 5,801.840579, 8,130.195641, and 9,286.49499) were observed between the responder (<jats:italic>n<\/jats:italic> = 7) and non-responder groups (<jats:italic>n<\/jats:italic> = 4) (<jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> We successfully established a series of diagnostic models involving RA and RA with complications as well as assessed disease activity. Furthermore, we found that CCL24 may be a valuable auxiliary diagnostic indicator for RA. These results provide reference values for clinical practice in the future.<\/jats:p>","DOI":"10.3389\/fmed.2021.609773","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:40:12Z","timestamp":1614141612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing Classification Tree Models in Rheumatoid Arthritis Using Combination of Matrix-Assisted Laser Desorption\/Ionization Time-of-Flight Mass Spectrometry and Magnetic Beads"],"prefix":"10.3389","volume":"8","author":[{"given":"Dan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The Lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med."},{"key":"B5","first-page":"448","article-title":"Secondary Sjogren's syndrome in 83 patients with rheumatoid arthritis","volume":"54","author":"Hajiabbasi","year":"2016","journal-title":"Acta Med Iran."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.60.12.1103","article-title":"Sicca symptoms and secondary Sj\u00f6gren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables","volume":"60","author":"Gilboe","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/bf00270286","article-title":"Histopathology of femoral head osteonecrosis in rheumatoid arthritis: the relationship between steroid therapy and lipid degeneration in the osteocyte","volume":"9","author":"Watanabe","year":"1989","journal-title":"Rheumatol Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.3390\/ijms20184368","article-title":"Proteomics approach for the discovery of rheumatoid arthritis biomarkers using mass spectrometry","volume":"20","author":"Mun","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/radiol.13130187","article-title":"Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern","volume":"270","author":"Assayag","year":"2014","journal-title":"Radiology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.crad.2004.04.014","article-title":"MRI of osteonecrosis","volume":"59","author":"Saini","year":"2004","journal-title":"Clin Radiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/01.moo.0000127829.34643.fd","article-title":"Osteonecrosis: etiology, diagnosis, and treatment","volume":"16","author":"Jones","year":"2004","journal-title":"Curr Opin Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jaut.2011.12.006","article-title":"Classification criteria for Sjogren's syndrome: a critical review","volume":"39","author":"Baldini","year":"2012","journal-title":"J Autoimmun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren's syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/annrheumdis-2012-201456","article-title":"Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study","volume":"72","author":"Gremese","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.3390\/molecules25204775","article-title":"Current status of Matrix-Assisted Laser Desorption\/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in clinical diagnostic microbiology","volume":"25","author":"Tsuchida","year":"2020","journal-title":"Molecules."},{"key":"B19","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.meegid.2019.104063","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: an updating review","volume":"76","author":"Angeletti","year":"2019","journal-title":"Infect Genet Evol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1373\/clinchem.2004.047308","article-title":"Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"51","author":"Baumann","year":"2005","journal-title":"Clin Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ab.2006.12.023","article-title":"Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers","volume":"362","author":"Whiteaker","year":"2007","journal-title":"Anal Biochem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/pmic.200900535","article-title":"Magnetic particles as powerful purification tool for high sensitive mass spectrometric screening procedures","volume":"10","author":"Peter","year":"2010","journal-title":"Proteomics."},{"key":"B23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ar.20870","article-title":"Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS","volume":"292","author":"Li","year":"2009","journal-title":"Anat Rec."},{"key":"B24","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/ar2644","article-title":"Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes","volume":"11","author":"Go\u00ebb","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/art.21607","article-title":"Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry ProteinChip approach","volume":"52","author":"de Seny","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/rheumatology\/kep058","article-title":"MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus","volume":"48","author":"Huang","year":"2009","journal-title":"Rheumatology (Oxford)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1586\/14789450.4.6.757","article-title":"Proteomic diagnosis of Sj\u00f6gren's syndrome","volume":"4","author":"Giusti","year":"2007","journal-title":"Expert Rev Proteomics."},{"key":"B28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3760\/cma.j.issn.0366-6999.2010.01.006","article-title":"Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry serum protein profiling","volume":"123","author":"Lin","year":"2010","journal-title":"Chin Med J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0009-8981(02)00170-5","article-title":"Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer","volume":"48","author":"Li","year":"2002","journal-title":"Clin Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1373\/clinchem.2005.052324","article-title":"Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology","volume":"51","author":"Cheng","year":"2005","journal-title":"Clin Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10238-013-0265-2","article-title":"Establishing serological classification tree model in rheumatoid arthritis using combination of MALDI-TOF-MS and magnetic beads","volume":"15","author":"Yan","year":"2015","journal-title":"Clin Exp Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10238-011-0154-5","article-title":"Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads","volume":"12","author":"Zhang","year":"2012","journal-title":"Clin Exp Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/1471-2474-11-143","article-title":"Decreased levels of CCR3 in CD4+ lymphocytes of rheumatoid arthritis patients","volume":"28","author":"Aloush","year":"2010","journal-title":"Clin Exp Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2249.2010.04172.x","article-title":"Protective effect of eotaxin-2inhibition in adjuvant-induced arthritis","volume":"161","author":"Ablin","year":"2010","journal-title":"Clin Exp Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s10517-014-2720-9","article-title":"Synthesis of some CC chemokines and their receptors in the synovium in rheumatoid arthritis","volume":"158","author":"Zhebrun","year":"2014","journal-title":"Bull Exp Biol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1021\/pr025531w","article-title":"Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid","volume":"1","author":"Uchida","year":"2002","journal-title":"J Proteome Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","author":"Karin","year":"2018","journal-title":"Cytokine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2172-13-2","article-title":"Jenh, M. Cox, L. Cui, E. Reich, L. Sullivan, S. Chen, et al. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection","volume":"13","year":"2012","journal-title":"BMC immunology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2567.2010.03384.x","article-title":"Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes","volume":"132","author":"Korniejewska","year":"2011","journal-title":"Immunology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3969\/j.issn.1671-167X.2012.02.017","article-title":"Screening for serum specific biomarkers in patients with primary Sj\u00f6gren's syndrome and interstitial lung disease using proteomic fingerprint techniques","volume":"44","author":"Li","year":"2012","journal-title":"Beijing Da Xue Xue Bao."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10067-014-2762-4","article-title":"Establishment of a novel diagnostic model for Sj\u00f6gren's syndrome by proteomic fingerprinting","volume":"33","author":"Li","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.trsl.2006.05.001","article-title":"Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head","volume":"148","author":"Tan","year":"2006","journal-title":"Transl Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard.2008.093153","article-title":"Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis","volume":"68","author":"Trocm\u00e9","year":"2009","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.609773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:40:15Z","timestamp":1614141615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.609773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":44,"alternative-id":["10.3389\/fmed.2021.609773"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.609773","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"article-number":"609773"}}